Myocardial Infarction in the Perioperative Setting (MIPS)

February 19, 2020 updated by: Max Bell, Karolinska University Hospital

Myocardial Infarction in the Perioperative Setting, a Swedish Multi Center Cohort Study

Acute myocardial infarction (AMI) is a significant complication following non-cardiac surgery. The investigators sought to evaluate incidence of perioperative AMI, its preoperative and intraoperative risk factors and the outcomes after this complication.

Study Overview

Detailed Description

Background:

In Sweden, over 800 000 patients undergo surgery each year. Worldwide, the number of surgical procedures yearly is over 310 million. Surgical care is an essential part of the advancement in treating disease, associated with increased life expectancy and improved quality of life. However, as surgical volume continues to grow, the number of patients who suffer postoperative complications will also increase.

More specifically the project aims to answer the following questions:

  1. How common is perioperative acute myocardial infarction following non-cardiac surgery?
  2. What are the preoperative and intraoperative risk factors for peroperative AMI?
  3. Does perioperative AMI affect mortality and morbidity, Length of stay and days at home?
  4. Is the risk of AMI affected by the type of hospital, region or calendar year of surgery?

Orbit - surgical planning system:

The study population was identified from 23 hospitals of all levels (university-, County- and district hospitals) in Sweden, that use the same software program to administer surgical procedures, between 1999 and 2015. The Orbit surgical planning system obligatory includes Swedish identity number, patient demographics, elective or non-elective status, date, type, extent and duration of anesthesia and surgery. Information of the American Society of Anesthesiologists (ASA) physical status classification was often available.

National Patient Register:

To obtain information on discharge dates, covariates and drug exposure, records of surgeries will be linked to the national patient register using the unique Swedish personal identification number assigned to all at birth or at immigration. The national registers have close to complete coverage. The Swedish cause of death registry includes the deaths of all Swedish citizens and residents with a national identity number; it is highly reliable with over 99% of all deaths reported. The Swedish Prescribed Drug Register became operational in July 2005 and contains data on all dispensed prescription of drugs in the Swedish population.

Swedeheart:

To identify all incident cases of myocardial infarctions, the surgical cohort will be linked to Swedeheart, a National Quality Registry containing data on all patients with acute myocardial infarction and all patients undergoing angiographic coronary intervention and heart surgery. The Swedeheart registry was developed in January 1995 and has a present coverage of 95% among incident cases of myocardial infarction treated at a cardiology department.

The National Board of Health and Welfare:

The National Board of Health and Welfare publishes statistics in the areas of health and medical care and social services, including data on acute myocardial infarction. The statistics include all persons aged 20 years and above who have had an acute myocardial infarction reported at the Hospital Discharge Register or the Cause of Death Register. Statistics are presented by year, sex, age and geographical area, information of incidence per 100 000 inhabitants is provided. These data were used to obtain information of expected cases of MI, for standardized incidence ratios (SIR) to be calculated.

Study Participants:

Patients aged 18 years or older undergoing elective or non-elective inpatients surgery between January 1, 2007 and December 31, 2014 were included. Exclusion criteria were surgeries in ambulatory care, cardiac surgery, obstetric- and minor surgical procedures. Patients were also excluded if the surgery was performed prior to 2007 or after 2014, and if a valid surgery code in Orbit - or if a corresponding surgery code in NPR - was lacking.

Study Type

Observational

Enrollment (Actual)

400742

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden, 17176
        • Karolinska University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Adult patients undergoing non-cardiac surgery between 2007 and 2014 in Swedish Hospitals using the Orbit software surgical planning tool. This software system is used in all parts of Sweden and in all types of hospitals (University, County and District hospitals)

  • University hospitals: Huddinge, KS, Norrlands universitetssjukhus, MAS, USIL, ** County hospitals: NU-sjukvården, Sundsvalls, Södra Älvsborgs, Örnsköldsviks *** District hospitals: Helsingborgs lasarett, Hässleholms, Kristanstads, Kullbergska, Landskrona, Lycksele, Mälarsjukhuset, Nyköping, Sollefteå, Skellefteå Södertälje, Trelleborg, Ystad, Ängelholm, Privat Ortopedisk klinik

Description

Inclusion Criteria:

  • Adults (≥18 years), male and female
  • Undergoing elective or non-elective inpatient noncardiac surgery

Exclusion Criteria:

  • Cardiac surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients undergoing surgery
Swedish patients, >18 years undergoing surgery 2007-2014
Neuro, Lung/thorax, GI, Gynecologic, Urologic, Orthopedic, Vascular surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acute Myocardial Infarction
Time Frame: Within 30days of the index surgery
AMI, as detected in the postoperative phase in the electronic medical records or in the Swedeheart registry
Within 30days of the index surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: Within 30days of the index surgery and at later predefined time points: 60, 90, 180 and 365 days after the index surgery
Death, as detected in the postoperative phase in the Swedish cause of death register
Within 30days of the index surgery and at later predefined time points: 60, 90, 180 and 365 days after the index surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of stay (LOS)
Time Frame: LOS within the year after the index surgery
Time spent in the hospital (number of days)
LOS within the year after the index surgery
Days at home alive within 30 days (DAH30)
Time Frame: DAH30 is counted within 30days of the index surgery
Time spent in the home after the index surgery, takes into account readmissions
DAH30 is counted within 30days of the index surgery
Risk of AMI and Mortality by gender, type of surgery, extent- and recency of comorbidity
Time Frame: Within one year of the index surgery
How above mentioned patient characteristics affect risk of AMI and mortality
Within one year of the index surgery
Secondary complications
Time Frame: Secondary complications within one year of the index surgery
AMI vs non-AMI patients and their risk of AKI, pneumonia, stroke, infections, thromboembolic complications
Secondary complications within one year of the index surgery
Outcomes (AMI+Mortality+Complications) by hospital, region and year
Time Frame: All outcomes within one year of the index surgery
All outcomes as affected by hospital type, region and by year
All outcomes within one year of the index surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

December 31, 2019

Study Registration Dates

First Submitted

February 7, 2019

First Submitted That Met QC Criteria

February 7, 2019

First Posted (Actual)

February 12, 2019

Study Record Updates

Last Update Posted (Actual)

February 20, 2020

Last Update Submitted That Met QC Criteria

February 19, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

De-identified cohort data for primary and secondary endpoints will be shared.

IPD Sharing Time Frame

Data will be available within a year of study completion

IPD Sharing Access Criteria

Data access will be reviewed by an external research committee at the department of perioperative medicine and intensive care at the Karolinska University Hospital

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Injury

Clinical Trials on Surgery

3
Subscribe